Geneva, March 23 -- International Clinical Trials Registry received information related to the study (EUCTR2026-000041-90-Outside-EU/EEA) titled 'Dymista in Chinese Adolescents' on March 5.
Study Type: Interventional clinical trial of medicinal product
Study Design:
Controlled: no Randomised: no Open: yes Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: no Other: no
Primary Sponsor: Meda Pharma GmbH & Co. KG (A Viatris Company)
Condition:
Moderate to severe seasonal and/or perennial Allergic Rhinitis with or without ocular symptoms
Seasonal Rhinitis: Term level: LLT, System organ class: Immune system disorders, Classification code:...